Liquid Biopsy for Personalised Monitoring of Melanoma Patients

用于黑色素瘤患者个性化监测的液体活检

• 批准号: nhmrc : 1117911
• 负责人: Dr Elin Gray
• 金额: $ 56万
• 依托单位: Edith Cowan University
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2019-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/liquid-biopsy-personalised-melanoma-patients/946297
• 关键词: Liquid; Biopsy; Personalised; Monitoring; Melanoma

Despite the success of recent melanoma treatments, therapies are effective long term in only a proportion of patients. Here we will progress preliminary findings in collaboration with biotechnology and pathology companies to develop highly effective companion biomarkers that will aid treatment decisions throughout disease course. Our team will spearhead translation of these markers into the clinic for routine monitoring of melanoma patients.

尽管最近的黑色素瘤治疗取得了成功，但只有一部分患者的治疗长期有效。在这里，我们将与生物技术和病理学公司合作，开发高效的伴随生物标志物，以帮助整个疾病过程中的治疗决策。我们的团队将率先将这些标志物转化为临床常规监测黑色素瘤患者。